Compare Agilent Technologies Inc (A) vs Nomura Holdings Inc (NMR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Agilent Technologies Inc vs Nomura Holdings Inc — how do they compare? Agilent Technologies Inc trades at $149.5 (market cap $42.22B), while Nomura Holdings Inc trades at $9.8 (market cap $28.46B). The key difference: Agilent Technologies Inc is the larger of the two by market cap, and Nomura Holdings Inc pays the higher dividend (3.31%). Which is the better fit depends on your goals.
| A | NMR | |
|---|---|---|
Market Cap | $42.22B | $28.46B |
Sector | Health | Financials |
52-Week High | $157.20 | $10.04 |
52-Week Low | $110.24 | $6.73 |
Enterprise Value | $43.77B | — |
Dividend Yield | 0.68% | 3.31% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About Nomura Holdings Inc
Nomura is Japan's largest broker, about twice the size of rival Daiwa Securities and roughly three times the size of the securities units of the three megabanks. It is also the largest asset-management company in Japan, with a similar size differential compared with its rivals. Despite its topnotch brand name in retail broking and asset management in Japan, Nomura has struggled to compete effectively in the institutional securities business against larger global rivals. In 2008, Nomura bought European and Asian assets of the failed Lehman Brothers, which led to a sharply higher cost base but did not provide commensurate revenue. Nomura has reduced the scale of these businesses but maintains its ambition to compete globally with the top players.
Read more on NMR →
